Clinical Trial Update: Re-Evaluation of GAmma3 Intramedullary Nails in Hip Fracture (REGAIN) [NA]

View source ↗

Summary

Clinical trial update on the REGAIN study evaluating the Gamma3 intramedullary nail for hip fractures; the trial status is completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Femoral Neck Fracture
• Intertrochanteric Fracture

Drugs mentioned

• Gamma3 intramedullary nail

Snippet

Sponsor: Stryker Trauma and Extremities | Conditions: Femoral Neck Fractures, Intertrochanteric Fracture | NA | Status: COMPLETED